Short communicationDecrease of Virus Receptors during Highly Pathogenic H5N1 Virus Infection in Humans and Other Mammals
Cited by (0)
Supported by the European Commission ANTIGONE grant FP7 278976 and FLUPIG grant FP7-GA258084.
Disclosures: A.D.M.E.O. performs no consultancies with companies on a personal title. Any consultancies performed are through contracts between Erasmus MC and any companies that desire consulting services. A.D.M.E.O. has share certificates in ViroClinics Biosciences B.V. The majority of the shares in ViroClinics Biosciences BV (>75%) are owned by Erasmus MC through its Erasmus MC Holding B.V. To avoid any possible conflict of interest and to safeguard its employees against the possibility of unethical decisions, the Erasmus MC does not allow any of its employees to hold shares in person in any companies that are (partly) owned by Erasmus MC. Any shares provided by such companies to any Erasmus MC employees are held by a Foundation Administration Office. The board of this foundation is appointed by Erasmus MC. The employees receive share certificates of their shares.